TrialAIDS research and human retroviruses2012

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Nicos Karasavvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.